Biodexa Pharmaceuticals Plc (BDRX)
NASDAQ: BDRX · Real-Time Price · USD
0.7950
-0.0358 (-4.31%)
Sep 9, 2026, 2:50 PM EDT - Market open
Biodexa Pharmaceuticals Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
11
Market Cap
818.11K USD
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | 381.00K | -318.00K | -45.49% |
| Dec 31, 2022 | 699.00K | 121.00K | 20.93% |
| Dec 31, 2021 | 578.00K | 235.00K | 68.51% |
| Dec 31, 2020 | 343.00K | -331.00K | -49.11% |
| Dec 31, 2019 | 674.00K | -1.26M | -65.22% |
| Dec 31, 2018 | 1.94M | 949.00K | 95.96% |
| Dec 31, 2017 | 989.00K | -334.00K | -25.25% |
| Dec 31, 2016 | 1.32M | -52.00K | -3.78% |
| Dec 31, 2015 | 1.38M | 1.22M | 775.80% |
| Dec 31, 2014 | 157.00K | 10.00K | 6.80% |
| Dec 31, 2013 | 147.00K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Jaguar Health | 27.82M |
| Scinai Immunotherapeutics | 1.49M |
| Decoy Therapeutics | 227.63K |
| Endovia Health Sciences | 32.09K |
| Virax Biolabs Group | 12.42K |
| Valion Bio | -86.00K |
BDRX News
- 21 days ago - Biodexa recruits 87 of 168 subjects in Serenta Phase 3 eRapa polyposis trial - TheFly
- 21 days ago - Biodexa announces major milestone for its Serenta registrational Phase 3 trial in FAP - GlobeNewsWire
- 5 weeks ago - Biodexa Pharmaceuticals Registration statement: Registration filing - Filings
- 5 weeks ago - Result of General Meeting - GlobeNewsWire
- 6 weeks ago - Biodexa Initiates Support Activities for FAP Patients and Treatment Centers in France - GlobeNewsWire
- 1 month ago - Biodexa Pharmaceuticals Registration statement: Registration filing - Filings
- 2 months ago - Result of Annual General Meeting - GlobeNewsWire
- 2 months ago - Biodexa Pharmaceuticals announces pricing of $3.5M registered offering - TheFly